Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.
HYPERTENSION, 2018 S. Eguchi +3 more
semanticscholar +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk +12 more
wiley +1 more source
Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema. [PDF]
Clin Transl AllergyDubrall D +22 more
europepmc +1 more source
Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect?
, 2007 Paul Ernsberger, Richard J. Koletsky
openalex +1 more source
Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia [PDF]
, 2017 Paulo Alexandre de Oliveira +12 more
openalex +1 more source
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
New England Journal of Medicine, 2001 J. Cohn, G. Tognoni
semanticscholar +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1194-1202, April 2025.Abstract Aims Cardiac decompensation in cardiorenal syndrome (CRS) results in systemic congestion usually treated with diuretics. When despite high doses of diuretics, response is poor, ultrafiltration (UF) appears to be a useful and safe technique.
Borja Guerrero Cervera +12 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies +23 more
wiley +1 more source
Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma. [PDF]
Cancer Diagn PrognIshikawa T +8 more
europepmc +1 more source
Transactivation of the Insulin-Like Growth Factor-I Receptor by Angiotensin II Mediates Downstream Signaling from the Angiotensin II Type 1 Receptor to Phosphatidylinositol 3-Kinase [PDF]
, 2004 Peter Zahradka +3 more
openalex +1 more source